ATLAS / Macro Radar / Reporting / CGEM

Cullinan Therapeutics, Inc. (CGEM) reporting calendar

Cullinan Therapeutics, Inc. files periodic reports with the SEC as CGEM on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 23 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CGEM market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-210304
10-K31 Dec 202510 Mar 202669 days0001193125-26-099362
10-Q30 Sep 20256 Nov 202537 days0001193125-25-268066
10-Q30 Jun 20257 Aug 202538 days0000950170-25-104551
10-Q31 Mar 20258 May 202538 days0000950170-25-066384
10-K31 Dec 202427 Feb 202558 days0000950170-25-028346
10-Q30 Sep 20247 Nov 202438 days0000950170-24-122795
10-Q30 Jun 20248 Aug 202439 days0000950170-24-093320
10-Q31 Mar 202415 May 202445 days0000950170-24-060535
10-K31 Dec 202314 Mar 202474 days0000950170-24-031143
10-Q30 Sep 20238 Nov 202339 days0000950170-23-060679
10-Q30 Jun 202310 Aug 202341 days0000950170-23-040964
10-Q31 Mar 202311 May 202341 days0000950170-23-021253
10-K31 Dec 20229 Mar 202368 days0000950170-23-006839
10-Q30 Sep 202214 Nov 202245 days0000950170-22-024683
10-Q30 Jun 202210 Aug 202241 days0000950170-22-016258
10-Q31 Mar 202216 May 202246 days0000950170-22-009937
10-K31 Dec 202117 Mar 202276 days0000950170-22-004002
10-Q30 Sep 20219 Nov 202140 days0001564590-21-055440
10-Q30 Jun 202110 Aug 202141 days0001564590-21-042872
10-Q31 Mar 202114 May 202144 days0001564590-21-027796
10-K31 Dec 202030 Mar 202189 days0001564590-21-016312

Source: SEC EDGAR company submissions for CIK 0001789972. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.